Peptidream, Inc. (4587) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

GNI Group Ltd.

OncoTherapy Science, Inc.

Cyfuse Biomedical KK

MEDINET Co., Ltd.

SUSMED, Inc.

Stella Pharma Corp.

Oncolys BioPharma, Inc.

Chiome Bioscience, Inc.

StemCell Institute

Peptidream, Inc.

Carna Biosciences, Inc.

Why is Peptidream, Inc. ?

With a fall in Operating Profit of -112.62%, the company declared Very Negative results in Jun 25

The company has declared negative results for the last 2 consecutive quarters
The company has declared negative results in Dec 24 after 2 consecutive negative quarters
INTEREST(HY) At JPY 367.06 MM has Grown at 169.22%
NET SALES(Q) At JPY 4,310.54 MM has Fallen at -63.07%
PRE-TAX PROFIT(Q) At JPY -1,408.22 MM has Fallen at -127.53%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -41.10%, its profits have risen by 507% ; the PEG ratio of the company is 0

Below par performance in long term as well as near term

Along with generating -41.10% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Peptidream, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Peptidream, Inc.

-40.4%

66.60

51.57%

Japan Nikkei 225

28.54%

1.14

25.81%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

50.80%

EBIT Growth (5y)

58.22%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

0.75

Net Debt to Equity (avg)

-0.30

Sales to Capital Employed (avg)

0.56

Tax Ratio

28.04%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

36.72%

ROE (avg)

19.37%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.02

EV to EBIT

9.65

EV to EBITDA

8.75

EV to Capital Employed

5.32

EV to Sales

4.37

PEG Ratio

0.03

Dividend Yield

ROCE (Latest)

55.15%

ROE (Latest)

27.06%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Bullish

Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

OPERATING CASH FLOW(Y)

Highest at JPY 15,552.33 MM

CASH AND EQV(HY)

Highest at JPY 68,805.07 MM

-40What is not working for the Company

INTEREST(HY)

At JPY 367.06 MM has Grown at 169.22%

NET SALES(Q)

At JPY 4,310.54 MM has Fallen at -63.07%

PRE-TAX PROFIT(Q)

At JPY -1,408.22 MM has Fallen at -127.53%

NET PROFIT(Q)

At JPY -1,089.11 MM has Fallen at -129.39%

ROCE(HY)

Lowest at -8.95%

RAW MATERIAL COST(Y)

Grown by 56.53% (YoY

INVENTORY TURNOVER RATIO(HY)

Lowest at 3.89%

DEBTORS TURNOVER RATIO(HY)

Lowest at 1%

Here's what is working for Peptidream, Inc.

Operating Cash Flow

Highest at JPY 15,552.33 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (JPY MM)

Cash and Eqv

Highest at JPY 68,805.07 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Here's what is not working for Peptidream, Inc.

Interest

At JPY 367.06 MM has Grown at 169.22%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Net Sales

At JPY 4,310.54 MM has Fallen at -63.07%

over average net sales of the previous four periods of JPY 11,671.15 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (JPY MM)

Pre-Tax Profit

At JPY -1,408.22 MM has Fallen at -127.53%

over average net sales of the previous four periods of JPY 5,114.38 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (JPY MM)

Net Profit

At JPY -1,089.11 MM has Fallen at -129.39%

over average net sales of the previous four periods of JPY 3,706.02 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (JPY MM)

Inventory Turnover Ratio

Lowest at 3.89%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 1%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 56.53% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales